Patel A R, Shah P C, Vohra R M, Hart W L, Shah J R
Arch Pathol Lab Med. 1980 Oct;104(10):509-12.
Data from 90 patients with a variety of hematologic malignant neoplasms were studied to determine the relation between changes in serum ferritin concentration and the clinical status of the patients. Patients with Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, blastic crisis of chronic myelocytic leukemia, acute myeloblastic leukemia and acute lymphoblastic leukemia were found to have significantly elevated serum ferritin levels. Further study of serum ferritin concentration in certain hematologic malignant neoplasms might provide a valuable insight into the role of serum ferritin determination in the diagnosis and follow-up of patients with malignant diseases.
对90例患有各种血液系统恶性肿瘤的患者的数据进行了研究，以确定血清铁蛋白浓度变化与患者临床状况之间的关系。发现患有霍奇金病、非霍奇金淋巴瘤、多发性骨髓瘤、慢性粒细胞白血病急变期、急性髓细胞白血病和急性淋巴细胞白血病的患者血清铁蛋白水平显著升高。对某些血液系统恶性肿瘤中血清铁蛋白浓度的进一步研究可能会为血清铁蛋白测定在恶性疾病患者的诊断和随访中的作用提供有价值的见解。
